We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Identification of a founder BRCA2 mutation in Sardinia.
- Authors
Pisano, M; Cossu, A; Persico, I; Palmieri, G; Angius, A; Casu, G; Palomba, G; Sarobba, M G; Rocca, P C Ossu; Dedola, M F; Olmeo, N; Pasca, A; Budroni, M; Marras, V; Pisano, A; Farris, A; Massarelli, G; Pirastu, M; Tanda, Francesco
- Abstract
Sardinian population can be instrumental in defining the molecular basis of cancer, using the identity-by-descent method. We selected seven Sardinian breast cancer families originating from the northern-central part of the island with multiple affected members in different generations. We genotyped 106 members of the seven families and 20 control nuclear families with markers flankingBRCA2 locus at 13q12-q13. The detection of a common haplotype shared by four out of seven families (60%) suggests the presence of a founderBRCA2 mutation. Direct sequencing ofBRCA2 coding exons of patients carrying the shared haplotype, allowed the identification of a 'frame-shift' mutation at codon 2867 (8765delAG), causing a premature termination-codon. This mutation was found in breast cancer patients as well as one prostate and one bladder cancer patient with shared haplotype. We then investigated the frequency of 8765delAG in the Sardinian breast cancer population by analysing 270 paraffin-embedded normal tissue samples from breast cancer patients. Five patients (1.7%) were found to be positive for the 8765delAG mutation. Discovery of a founder mutation in Sardinia through the identity-by-descent method demonstrates that this approach can be applied successfully to find mutations either for breast cancer or for other types of tumours.
- Subjects
BREAST cancer; GENETIC mutation
- Publication
British Journal of Cancer, 2000, Vol 82, Issue 3, p553
- ISSN
0007-0920
- Publication type
Article
- DOI
10.1054/bjoc.1999.0963